alisol b has been researched along with 22,23-dihydroavermectin b(1)a in 1 studies
| Studies (alisol b) | Trials (alisol b) | Recent Studies (post-2010) (alisol b) | Studies (22,23-dihydroavermectin b(1)a) | Trials (22,23-dihydroavermectin b(1)a) | Recent Studies (post-2010) (22,23-dihydroavermectin b(1)a) |
|---|---|---|---|---|---|
| 5 | 0 | 5 | 21 | 1 | 14 |
| Protein | Taxonomy | alisol b (IC50) | 22,23-dihydroavermectin b(1)a (IC50) |
|---|---|---|---|
| 60 kDa chaperonin | Escherichia coli | 9.5 | |
| 10 kDa chaperonin | Escherichia coli | 9.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kmoníčková, E; Peterková, L; Rimpelová, S; Ruml, T | 1 |
1 review(s) available for alisol b and 22,23-dihydroavermectin b(1)a
| Article | Year |
|---|---|
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
Topics: Animals; Antineoplastic Agents; Enzyme Inhibitors; Gene Regulatory Networks; Humans; Neoplasms; Protein Structure, Secondary; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2020 |